Sale!

COL1A2 Gene Osteogenesis Imperfecta Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COL1A2 gene plays a critical role in the development and functioning of connective tissues in the body. Mutations in this gene are associated with Osteogenesis Imperfecta (OI), a group of genetic disorders characterized by brittle bones that break easily, often with little or no apparent cause. The COL1A2 gene encodes the pro-alpha2 chain of type I collagen, a major structural component of bones.

To diagnose and assess the risk of Osteogenesis Imperfecta, a genetic test targeting the COL1A2 gene can be performed. This test involves analyzing the DNA to identify mutations in the COL1A2 gene that are known to cause OI. Identifying a mutation can help in confirming a diagnosis of OI, understanding the severity of the condition, and guiding treatment options. It can also provide valuable information for family planning and genetic counseling for affected families.

In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the COL1A2 Gene Osteogenesis Imperfecta Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted with high precision and accuracy, ensuring reliable results for patients and their families. This facility is equipped with state-of-the-art technology and staffed by experts in genetic testing, providing a crucial resource for individuals and families affected by Osteogenesis Imperfecta.

Description

COL1A2 Gene Osteogenesis imperfecta Genetic Test

Components: COL1A2 gene

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for COL1A2 Gene Osteogenesis imperfecta NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL1A2 Gene Osteogenesis imperfecta NGS Genetic DNA Test gene COL1A2

Test Details: The COL1A2 gene is a gene that provides instructions for making a protein called type I collagen. This protein is a major component of connective tissues, such as the skin, bones, and tendons. Osteogenesis imperfecta (OI) is a genetic disorder that affects the production of type I collagen. It is characterized by brittle bones that are prone to fractures, as well as other symptoms such as blue sclerae (the white part of the eyes), hearing loss, and dental problems. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the context of osteogenesis imperfecta, NGS can be used to analyze the COL1A2 gene for any mutations or variations that may be associated with the disorder. By performing an NGS genetic test on the COL1A2 gene, healthcare professionals can identify specific genetic changes that may be causing osteogenesis imperfecta in an individual. This information can be helpful for diagnosis, genetic counseling, and potentially guiding treatment decisions.

Test Name	COL1A2 Gene Osteogenesis imperfecta Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for COL1A2 Gene Osteogenesis imperfecta NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL1A2 Gene Osteogenesis imperfecta NGS Genetic DNA Test gene COL1A2
Test Details	The COL1A2 gene is a gene that provides instructions for making a protein called type I collagen. This protein is a major component of connective tissues, such as the skin, bones, and tendons. Osteogenesis imperfecta (OI) is a genetic disorder that affects the production of type I collagen. It is characterized by brittle bones that are prone to fractures, as well as other symptoms such as blue sclerae (the white part of the eyes), hearing loss, and dental problems. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the context of osteogenesis imperfecta, NGS can be used to analyze the COL1A2 gene for any mutations or variations that may be associated with the disorder. By performing an NGS genetic test on the COL1A2 gene, healthcare professionals can identify specific genetic changes that may be causing osteogenesis imperfecta in an individual. This information can be helpful for diagnosis, genetic counseling, and potentially guiding treatment decisions.